vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and ROGERS CORP (ROG). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $201.5M, roughly 1.8× ROGERS CORP). ROGERS CORP runs the higher net margin — 2.3% vs -0.8%, a 3.1% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 4.8%). ROGERS CORP produced more free cash flow last quarter ($42.2M vs $36.1M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -2.8%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
ASIX vs ROG — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $201.5M |
| Net Profit | $-2.8M | $4.6M |
| Gross Margin | 7.6% | 31.5% |
| Operating Margin | -0.7% | 3.5% |
| Net Margin | -0.8% | 2.3% |
| Revenue YoY | 9.4% | 4.8% |
| Net Profit YoY | -892.9% | 1020.0% |
| EPS (diluted) | $-0.11 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $201.5M | ||
| Q3 25 | $374.5M | $216.0M | ||
| Q2 25 | $410.0M | $202.8M | ||
| Q1 25 | $377.8M | $190.5M | ||
| Q4 24 | $329.1M | $192.2M | ||
| Q3 24 | $398.2M | $210.3M | ||
| Q2 24 | $453.5M | $214.2M | ||
| Q1 24 | $336.8M | $213.4M |
| Q4 25 | $-2.8M | $4.6M | ||
| Q3 25 | $-2.6M | $8.6M | ||
| Q2 25 | $31.4M | $-73.6M | ||
| Q1 25 | $23.3M | $-1.4M | ||
| Q4 24 | $352.0K | $-500.0K | ||
| Q3 24 | $22.3M | $10.7M | ||
| Q2 24 | $38.9M | $8.1M | ||
| Q1 24 | $-17.4M | $7.8M |
| Q4 25 | 7.6% | 31.5% | ||
| Q3 25 | 6.8% | 33.5% | ||
| Q2 25 | 14.3% | 31.6% | ||
| Q1 25 | 14.2% | 29.9% | ||
| Q4 24 | 3.4% | 32.1% | ||
| Q3 24 | 14.4% | 35.2% | ||
| Q2 24 | 17.9% | 34.1% | ||
| Q1 24 | 0.9% | 32.0% |
| Q4 25 | -0.7% | 3.5% | ||
| Q3 25 | -0.9% | 7.3% | ||
| Q2 25 | 7.7% | -33.3% | ||
| Q1 25 | 7.7% | -0.2% | ||
| Q4 24 | -3.9% | -6.6% | ||
| Q3 24 | 7.5% | 6.9% | ||
| Q2 24 | 11.5% | 5.3% | ||
| Q1 24 | -7.0% | 5.5% |
| Q4 25 | -0.8% | 2.3% | ||
| Q3 25 | -0.7% | 4.0% | ||
| Q2 25 | 7.7% | -36.3% | ||
| Q1 25 | 6.2% | -0.7% | ||
| Q4 24 | 0.1% | -0.3% | ||
| Q3 24 | 5.6% | 5.1% | ||
| Q2 24 | 8.6% | 3.8% | ||
| Q1 24 | -5.2% | 3.7% |
| Q4 25 | $-0.11 | $0.20 | ||
| Q3 25 | $-0.10 | $0.48 | ||
| Q2 25 | $1.15 | $-4.00 | ||
| Q1 25 | $0.86 | $-0.08 | ||
| Q4 24 | $0.02 | $-0.04 | ||
| Q3 24 | $0.82 | $0.58 | ||
| Q2 24 | $1.43 | $0.44 | ||
| Q1 24 | $-0.65 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $197.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $1.2B |
| Total Assets | $1.7B | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $197.0M | ||
| Q3 25 | $23.7M | $167.8M | ||
| Q2 25 | $18.4M | $157.2M | ||
| Q1 25 | $8.3M | $175.6M | ||
| Q4 24 | $19.6M | $159.8M | ||
| Q3 24 | $17.3M | $146.4M | ||
| Q2 24 | $12.1M | $119.9M | ||
| Q1 24 | $20.6M | $116.9M |
| Q4 25 | $815.2M | $1.2B | ||
| Q3 25 | $818.2M | $1.2B | ||
| Q2 25 | $823.7M | $1.2B | ||
| Q1 25 | $794.4M | $1.3B | ||
| Q4 24 | $774.6M | $1.3B | ||
| Q3 24 | $766.4M | $1.3B | ||
| Q2 24 | $746.6M | $1.3B | ||
| Q1 24 | $713.2M | $1.3B |
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.5B | ||
| Q1 24 | $1.5B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $46.9M |
| Free Cash FlowOCF − Capex | $36.1M | $42.2M |
| FCF MarginFCF / Revenue | 10.0% | 20.9% |
| Capex IntensityCapex / Revenue | 7.7% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 10.20× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $71.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $46.9M | ||
| Q3 25 | $26.6M | $28.9M | ||
| Q2 25 | $21.1M | $13.7M | ||
| Q1 25 | $11.4M | $11.7M | ||
| Q4 24 | $64.2M | $33.7M | ||
| Q3 24 | $57.3M | $42.4M | ||
| Q2 24 | $50.2M | $22.9M | ||
| Q1 24 | $-36.2M | $28.1M |
| Q4 25 | $36.1M | $42.2M | ||
| Q3 25 | $66.0K | $21.2M | ||
| Q2 25 | $-7.2M | $5.6M | ||
| Q1 25 | $-22.6M | $2.1M | ||
| Q4 24 | $29.8M | $18.3M | ||
| Q3 24 | $26.8M | $25.2M | ||
| Q2 24 | $16.7M | $8.8M | ||
| Q1 24 | $-71.6M | $18.7M |
| Q4 25 | 10.0% | 20.9% | ||
| Q3 25 | 0.0% | 9.8% | ||
| Q2 25 | -1.7% | 2.8% | ||
| Q1 25 | -6.0% | 1.1% | ||
| Q4 24 | 9.1% | 9.5% | ||
| Q3 24 | 6.7% | 12.0% | ||
| Q2 24 | 3.7% | 4.1% | ||
| Q1 24 | -21.3% | 8.8% |
| Q4 25 | 7.7% | 2.3% | ||
| Q3 25 | 7.1% | 3.6% | ||
| Q2 25 | 6.9% | 4.0% | ||
| Q1 25 | 9.0% | 5.0% | ||
| Q4 24 | 10.4% | 8.0% | ||
| Q3 24 | 7.7% | 8.2% | ||
| Q2 24 | 7.4% | 6.6% | ||
| Q1 24 | 10.5% | 4.4% |
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | 3.96× | ||
| Q2 24 | 1.29× | 2.83× | ||
| Q1 24 | — | 3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
ROG
| Elastomeric Material Solutions | $80.5M | 40% |
| Transferred At Point In Time | $69.7M | 35% |
| Transferred Over Time | $47.6M | 24% |
